Eloxx Pharmaceuticals Inc: Signed Global Licensing Partnership for Zkn-013 With Almirall Pharmaceuticals With $3M Upfront and up to $470M in Milestones
Eloxx Pharmicals Inc:與 Almirall Pharmicals 簽署了 Zkn-013 全球許可合作伙伴關係,預付資金爲 300 萬美元,里程碑高達 4.7 億美元
Eloxx Pharmaceuticals Inc: Signed Global Licensing Partnership for Zkn-013 With Almirall Pharmaceuticals With $3M Upfront and up to $470M in Milestones
Eloxx Pharmicals Inc:與 Almirall Pharmicals 簽署了 Zkn-013 全球許可合作伙伴關係,預付資金爲 300 萬美元,里程碑高達 4.7 億美元
使用瀏覽器的分享功能,分享給你的好友吧